NCT03147599View on ClinicalTrials.gov

Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

May 15, 2017

Primary Completion Date

May 1, 2019

Study Completion Date

May 1, 2019

Conditions
OncologyIncontinenceIncontinence, Daytime UrinaryIncontinence, Nighttime UrinaryBladder CancerOrthotopic Neobladder
Interventions
DRUG

Coloverin

Mebeverine hydrochloride 135 mg

DRUG

Placebo

Placebo

Trial Locations (1)

35516

Urology and Nephrology Center, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT03147599 - Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders | Biotech Hunter | Biotech Hunter